Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe now
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About Hardman & Co.
Case Studies
Our team
News & events
The EIS Navigator Podcast
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Subscribe now
Receive our latest research as soon as it is published
Investment Research & Analysis
Detailed company analysis created for specifically for investors
Tax Enhanced Services
Product reports for investors and advisors
Bespoke Services
Services for clients with specific needs
About Hardman & Co.
We are the longest-established commissioned research provider. Read our story
Case Studies
We help a wide range of clients with different needs. Read what they say about us
Our Team
Meet the Hardman & Co team members
COVID-19: -
Our Commitment to Client Service & Investor Communications
Latest Corporate research
Our research can still be accessed for free under MIFID II.
Find out more >
All Corporate research
- Update
- Monthly Report
- Sector Report
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Utilities
list companies
City of London Investment Group
Financials
Boost from positive markets and deal completion
By
Dr Brian Moretta
13 Oct 2020
Pantheon International Plc
Financials
Returns, resilience and responsibility
By
Mark Thomas
09 Oct 2020
Stay up-to-date with the latest research
Sign up to our newsletter
Tissue Regenix
Life Sciences
Funded through to profitability
By
Dr Martin Hall
07 Oct 2020
Advanced Oncotherapy
Life Sciences
Progress towards commissioning of first LIGHT
By
Dr Martin Hall
07 Oct 2020
Cars – generating different attitudes?
By
Derek Terrington
06 Oct 2020
The Monthly: October 2020
01 Oct 2020
Diurnal Group Plc
Life Sciences
And then there were three
By
Dr Martin Hall
30 Sep 2020
Chamberlin Plc
Industrial
Trading update most encouraging
By
Paul Singer
29 Sep 2020
Arix Bioscience
Life Sciences
Realising the valuation disconnect
By
Dr Martin Hall
21 Sep 2020
Shield Therapeutics Plc
Life Sciences
Optimism over US deal
By
Dr Martin Hall
18 Sep 2020
City of London Investment Group
Financials
Solid results, with surprise dividend increase
By
Dr Brian Moretta
17 Sep 2020
1
2
3
...
43
Next
